# Altimmune, Inc.: Form 8-K, filed Feb 3, 2026

- Company: [Altimmune, Inc.](/companies/alt.md) (CIK 1326190)
- Form: 8-K
- Filed: 2026-02-03
- Accepted by EDGAR: Feb 3, 2026, 16:05 ET
- Period: 2026-02-02
- Accession: 0001326190-26-000008
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326190/000132619026000008/alt-20260202x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326190/000132619026000008/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326190/000132619026000008/alt-20260202x8k.htm

Filed Feb 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001326190-26-000008. Last ingested by Listed: Nov 14, 2026, 20:51 ET. No prices; not investment advice.
